-
Something wrong with this record ?
Neurotransplantation therapy
J. Cendelin, H. Mitoma,
Language English Country Netherlands
Document type Journal Article, Review
- MeSH
- Cerebellar Ataxia surgery MeSH
- Humans MeSH
- Disease Models, Animal MeSH
- Brain Tissue Transplantation methods MeSH
- Animals MeSH
- Check Tag
- Humans MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
- Review MeSH
Neurotransplantation may be a promising approach for therapy of cerebellar diseases characterized by a substantial loss of neurons. Neurotransplantation could rescue neurons from degeneration and maintain cerebellar reserve, facilitate cerebellar compensation, or help reconstruct damaged neural circuits by cell substitution. These mechanisms of action can be of varying importance according to the type of cerebellar disease. Neurotransplantation therapy in cerebellar ataxias is still at the stage of experimental studies. There is currently little knowledge regarding cerebellar patients. Nevertheless, data provided by experiments in animal models of cerebellar degeneration and both clinical studies and experiences in patients with other neurologic diseases enable us to suggest basic principles, expectations, limitations, and future directions of neurotransplantation therapy for cerebellar diseases.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc19000651
- 003
- CZ-PrNML
- 005
- 20190111163142.0
- 007
- ta
- 008
- 190107s2018 ne f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/B978-0-444-64189-2.00025-1 $2 doi
- 035 __
- $a (PubMed)29891073
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ne
- 100 1_
- $a Cendelin, Jan $u Department of Pathological Physiology and Laboratory of Neurodegenerative Disorders, Biomedical Center, Faculty of Medicine, Charles University, Pilsen, Czech Republic. Electronic address: jan.cendelin@lfp.cuni.cz.
- 245 10
- $a Neurotransplantation therapy / $c J. Cendelin, H. Mitoma,
- 520 9_
- $a Neurotransplantation may be a promising approach for therapy of cerebellar diseases characterized by a substantial loss of neurons. Neurotransplantation could rescue neurons from degeneration and maintain cerebellar reserve, facilitate cerebellar compensation, or help reconstruct damaged neural circuits by cell substitution. These mechanisms of action can be of varying importance according to the type of cerebellar disease. Neurotransplantation therapy in cerebellar ataxias is still at the stage of experimental studies. There is currently little knowledge regarding cerebellar patients. Nevertheless, data provided by experiments in animal models of cerebellar degeneration and both clinical studies and experiences in patients with other neurologic diseases enable us to suggest basic principles, expectations, limitations, and future directions of neurotransplantation therapy for cerebellar diseases.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a transplantace mozkové tkáně $x metody $7 D016380
- 650 _2
- $a cerebelární ataxie $x chirurgie $7 D002524
- 650 _2
- $a modely nemocí na zvířatech $7 D004195
- 650 _2
- $a lidé $7 D006801
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Mitoma, Hiroshi $u Department of Medical Education, Tokyo Medical University, Tokyo, Japan.
- 773 0_
- $w MED00191576 $t Handbook of clinical neurology $x 0072-9752 $g Roč. 155, č. - (2018), s. 379-391
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/29891073 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20190107 $b ABA008
- 991 __
- $a 20190111163347 $b ABA008
- 999 __
- $a ok $b bmc $g 1364690 $s 1038774
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2018 $b 155 $c - $d 379-391 $i 0072-9752 $m Handbook of Clinical Neurology $n Handb Clin Neurol $x MED00191576
- LZP __
- $a Pubmed-20190107